{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:16:33Z","timestamp":1775128593201,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.seizure.2017.02.014","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T18:31:13Z","timestamp":1488220273000},"page":"9-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Upregulation of breast cancer resistance protein and major vault protein in drug resistant epilepsy"],"prefix":"10.1016","volume":"47","author":[{"given":"Aparna","family":"Banerjee Dixit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devina","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpna","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotirmoy","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sarat Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2017.02.014_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(98)00106-5","article-title":"Clinical aspects and biological bases of drug-resistant epilepsies","volume":"34","author":"Regesta","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.02.014_bib0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/S1092852900008464","article-title":"The consequences of uncontrolled epilepsy","volume":"9","author":"Sperling","year":"2004","journal-title":"CNS Spectr"},{"key":"10.1016\/j.seizure.2017.02.014_bib0015","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Disease-related factors are certainly important, including the etiology of the seizures, progression of epilepsy under treatment with AEDs, alterations in drug targets, or alterations in drug uptake into the brain","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.02.014_bib0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1528-1167.2005.00356.x","article-title":"Genetics of drug resistance","volume":"46","author":"Sisodiya","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.02.014_bib0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yebeh.2008.08.019","article-title":"No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population","volume":"14","author":"Lakhan","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2017.02.014_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2133\/dmpk.24.255","article-title":"Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an Indian population","volume":"24","author":"Vahab","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.seizure.2017.02.014_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.10.023","article-title":"Role of inflammation and its miRNA based regulation in epilepsy:Implications for therapy","volume":"452","author":"Srivastava","year":"2016","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.seizure.2017.02.014_bib0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygeno.2016.04.001","article-title":"RNA-Seq analysis of hippocampal tissues reveals novel candidate genes for drug refractory epilepsy in patients with MTLE-HS","volume":"107","author":"Dixit","year":"2016","journal-title":"Genomics"},{"key":"10.1016\/j.seizure.2017.02.014_bib0045","first-page":"23","article-title":"The blood brain barrier in epilepsy. Chapter 2. Clinical and Genetic Aspects of Epilepsy","volume":"2","author":"Bauer","year":"2011"},{"key":"10.1016\/j.seizure.2017.02.014_bib0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/jpet.301.1.7","article-title":"Role of multidrug transporters in pharmacoresistance to antiepileptic drugs","volume":"30","author":"L\u00f6scher","year":"2002","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.seizure.2017.02.014_bib0055","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.0013-9580.2004.57703.x","article-title":"Expression and cellular distribution of multidrug resistance\u2013related proteins in the hippocampus of patients with mesial temporal lobe epilepsy","volume":"45","author":"Aronica","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.02.014_bib0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-642-14541-4_8","article-title":"Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy","volume":"201","author":"Keppler","year":"2011","journal-title":"Handbook Exp Pharmacol"},{"key":"10.1016\/j.seizure.2017.02.014_bib0065","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2005.00250.x","article-title":"Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats","volume":"46","author":"Van Vliet","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.02.014_bib0070","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1046\/j.1528-1157.2003.21803.x","article-title":"Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy","volume":"44","author":"Sisodiya","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.02.014_bib0075","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/epi.12318","article-title":"Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains","volume":"54","author":"Ghosh","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.02.014_bib0080","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1528-1167.2005.66604.x","article-title":"Localization of Breast Cancer Resistance Protein (BCRP) in microvessel endothelium of human control and epileptic brain","volume":"46","author":"Aronica","year":"2005","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:47:46Z","timestamp":1761011266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131117301462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":16,"alternative-id":["S1059131117301462"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.02.014","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of breast cancer resistance protein and major vault protein in drug resistant epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}